PMV Capital Advisers’s Dentsply Sirona XRAY Stock Holding History

PMV Capital Advisers’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17	Closed	-$193	–	124
2026 Q1	$193	Buy	+17	New	+$212	﹤0.01%	92

Other funds holding XRAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

PMV Capital Advisers's XRAY Position: Q2 2026 in Review

PMV Capital Advisers sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 17 shares — an estimated $193 sold.

PMV Capital Advisers first reported a position in XRAY in Q1 2026 and held it in 1 quarter. The position peaked at $193 in Q1 2026. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

PMV Capital Advisers reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
PMV Capital Advisers sold 17 Dentsply Sirona shares in Q2 2026, an estimated $193.
PMV Capital Advisers first reported a position in Dentsply Sirona in Q1 2026 and held it in 1 quarter.
PMV Capital Advisers's Dentsply Sirona position peaked at $193 in Q1 2026.
374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on PMV Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.